IDEAYA Biosciences, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $198.3M | $72.0M |
| FY2021 | — | $301.5M | $92.0M |
| FY2022 | — | $349.5M | $68.6M |
| FY2023 | — | $621.1M | $157.0M |
| FY2024 | — | $1.06B | $84.4M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2020 | — | $198.3M | $72.0M |
| FY2021 | — | $301.5M | $92.0M |
| FY2022 | — | $349.5M | $68.6M |
| FY2023 | — | $621.1M | $157.0M |
| FY2024 | — | $1.06B | $84.4M |